kwyjibo87 writes: The World Health Organization (WHO) publicly expressed dismay yesterday concerning news that intellectual property claims were hindering research on a deadly new emerging virus. Novel coronavirus (nCoV), a member of the same viral genus as the causative agent of SARS, has claimed the lives of 22 people (out of 44 reported infected) and left both researchers and health officials scrambling to develop effective diagnostic tests in addition to possible medications and vaccines against nCoV. Now, however, claims of intellectual property on the new virus are hindering research on nCoV according to the WHO, delaying advancements on tools to prevent further spread of the infection. Stories of intellectual property rights in science hindering advancements in research, particularly in clinical applications, are nothing new; the US Supreme Court recently heard arguments on the validity of patents on the BRCA1/2 genes and has yet to issue a decision. The issue of sharing scientific information in order to promote faster research on emerging pathogens is not limited to intellectual property — a recent article in the journal Nature highlighted a case where Chinese researchers risked having their research scooped after uploading viral sequences to a public database designed aid global scientific collaboration.